Research and analysis

Monitoring of vaccine-induced HPV seroprevalence in England

Post-immunisation monitoring of vaccine-induced human papillomavirus seroprevalence in England


Post-immunisation monitoring of HPV vaccine-induced seroprevalence in England 2010-2013

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


Data, and related commentary, arising from the surveillance of young women offered HPV vaccination aimed at comparing vaccine-induced seroprevalence to nationally reported coverage data.

Part of the collection, “Genital warts and human papillomavirus (HPV): guidance, data and analysis”.

Published 7 October 2016